Clinical Report: The Use of Remote Monitoring in Care Management for Bone Marrow Transplant Patients

Overview

This study evaluates the feasibility and acceptability of remote patient monitoring (RPM) for early detection of febrile neutropenia (FN) in allogeneic bone marrow transplant (BMT) patients. RPM may enhance timely intervention and improve patient outcomes by facilitating early detection of infection-related symptoms.

Background

Febrile neutropenia (FN) is a significant complication in cancer patients, particularly those undergoing bone marrow transplantation, where the incidence can reach up to 80%. Timely administration of antibiotics is critical, as delays can lead to increased morbidity and mortality. Remote monitoring technologies may provide a solution to improve early detection and management of FN in this vulnerable population.

Data Highlights

No numerical data was provided in the source material.

Key Findings

• FN occurs in up to 50% of chemotherapy patients, with BMT patients at an 80% risk.
• Delays in antibiotic administration for FN can increase 28-day mortality risk by 18% for each hour of delay.
• Remote patient monitoring (RPM) can improve early detection of clinical indicators in patients.
• The Cancer Care at Home program integrates RPM with virtual care teams for BMT patients.
• Timely intervention through RPM may reduce hospital stays and improve patient outcomes.

Clinical Implications

Healthcare providers should consider implementing RPM systems to enhance monitoring of BMT patients for early signs of FN. This technology could facilitate quicker interventions, potentially reducing the risk of severe infections and improving overall patient management.

Conclusion

The integration of remote monitoring in the care of BMT patients presents a promising approach to enhance early detection of febrile neutropenia and improve clinical outcomes. Further studies are warranted to validate these findings and optimize implementation strategies.

References

1. Casanovas-Blanco & Serrahima-Mackay, 2020 -- Febrile Neutropenia Overview
2. Taplitz et al., 2018b -- Guidelines for Antibiotic Administration in FN
3. Alvarez et al., 2021 -- Remote Monitoring in Cancer Care
4. Jacobsen et al., 2022 -- RPM in Oncology
5. the asco post — New Application May Help Caregivers of Patients Undergoing Bone Marrow Transplant
6. fox chase cancer center — Home-Based Monitoring Could Transform Care for Patients Receiving T-Cell Redirecting Therapies
7. ophthalmology management — The Promise of Home Monitoring
8. Ophthalmology Management — The Promise of Home Monitoring
9. New Application May Help Caregivers of Patients Undergoing Bone Marrow Transplant
10. Home-Based Monitoring Could Transform Care for Patients Receiving T-Cell Redirecting Therapies
11. The Promise of Home Monitoring
12. Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia - PubMed
13. RESEARCH & SCHOLARSHIP
14. Study Details | NCT05662631 | Remote Monitoring and Home-based Health Care for Treatment of Bone Marrow Transplant Patients | ClinicalTrials.gov